Invention Application
WO2013063544A1 MIRNAS AS DIAGNOSTIC BIOMARKERS TO DISTINGUISH BENIGN FROM MALIGNANT THYROID TUMORS 审中-公开
MIRNAS作为诊断生物标志物从恶性甲状腺肿瘤中辨别

  • Patent Title: MIRNAS AS DIAGNOSTIC BIOMARKERS TO DISTINGUISH BENIGN FROM MALIGNANT THYROID TUMORS
  • Patent Title (中): MIRNAS作为诊断生物标志物从恶性甲状腺肿瘤中辨别
  • Application No.: PCT/US2012/062330
    Application Date: 2012-10-27
  • Publication No.: WO2013063544A1
    Publication Date: 2013-05-02
  • Inventor: BEAUDENON-HUIBREGTSE, SylvieWYLIE, DennisADAI, Alex, T.
  • Applicant: ASURAGEN, INC.
  • Applicant Address: 2150 Woodward St., Suite 100 Austin, TX 78744 US
  • Assignee: ASURAGEN, INC.
  • Current Assignee: ASURAGEN, INC.
  • Current Assignee Address: 2150 Woodward St., Suite 100 Austin, TX 78744 US
  • Agency: SHISHIMA, Gina, N.
  • Priority: US61/552,451 20111027; US61/552,762 20111028
  • Main IPC: C12Q1/68
  • IPC: C12Q1/68
MIRNAS AS DIAGNOSTIC BIOMARKERS TO DISTINGUISH BENIGN FROM MALIGNANT THYROID TUMORS
Abstract:
Embodiments concern methods and compositions for distinguishing benign from malignant thyroid tumors in a patient based on the expression levels of one or more miRNAs.
Patent Agency Ranking
0/0